Get started
Author

Whitney Espinel

Observed names: Espinel, Whitney F., W Espinel, Whitney F Espinel, Whitney F. Espinel, Whitney F. Maxwell, Whitney Maxwell
Observed institutions: Brigham Young University, Emory University, University of Utah, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Huntsman Cancer Institute, Dana-Farber Cancer Institute
ORCID: 0000-0002-7159-9239
Observed ORCID: 0000-0002-7159-9239
OpenAlex ID: A5009502871
Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models
2024 · Kimberly A. Kaphingst, Wendy K. Kohlmann, et al. · JAMA Network Open · 53
PDF
Patient Interactions With an Automated Conversational Agent Delivering Pretest Genetics Education: Descriptive Study
2021 · Daniel Chavez-Yenter, Kadyn E Kimball, et al. · Journal of Medical Internet Research · 43
PDF
Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial
2021 · Kimberly A. Kaphingst, Wendy Kohlmann, et al. · BMC Health Services Research · 37
Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults
2020 · Nykole Sutherland, Whitney Espinel, et al. · Journal of Genetic Counseling · 25
Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing
2019 · Samantha Greenberg, Saundra S. Buys, et al. · Cancer Medicine · 22
PDF
Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study
2014 · Emily G. Allen, Wendy E. Grus, et al. · Frontiers in Genetics · 19
PDF
Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer Genes
2019 · Emily W. Moody, Jennie Vagher, et al. · JCO Precision Oncology · 17
The diagnostic experience of women with fragile X–associated primary ovarian insufficiency (FXPOI)
2022 · Bonnie Poteet, Nadia Ali, et al. · Journal of Assisted Reproduction and Genetics · 12
Improving Health Education for Women Who Carry an FMR1 Premutation
2015 · Whitney Espinel, Krista Charen, et al. · Journal of Genetic Counseling · 10
Bridging Technology and Pretest Genetic Services: Quantitative Study of Chatbot Interaction Patterns, User Characteristics, and Genetic Testing Decisions
2025 · Yang Yi, Lauren Kaiser-Jackson, et al. · Journal of Medical Internet Research · 8
PDF
Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer Patients
2022 · Whitney Espinel, Marjan Champine, et al. · Cancers · 7
PDF
The Effects of At-Birth Adoption on Atypical Behavior and Anxiety: A Nonhuman Primate Model
2021 · Elizabeth K. Wood, Whitney F. Espinel, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 7
Social vulnerability and genetic service utilization among unaffected BRIDGE trial patients with inherited cancer susceptibility
2025 · Jemar R. Bather, Melody S. Goodman, et al. · BMC Cancer · 5
PDF
Predictors of Women’s Intentions to Communicate Updated Genetic Test Results to Immediate and Extended Family Members
2023 · Carolyn Winskill, Melody S. Goodman, et al. · Public Health Genomics · 5
PDF
Uptake of genetic counseling and multi‐gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing
2021 · Ryan Mooney, Whitney Espinel, et al. · Journal of Genetic Counseling · 5
Implications of Multigene Panel Testing on Psychosocial Outcomes: A Comparison of Patients With Pancreatic and Breast or Ovarian Cancer
2021 · Cathryn Koptiuch, Whitney F. Espinel, et al. · JCO Precision Oncology · 3
Investigating genetic counselors' communication with Lynch syndrome patients about cascade testing: Barriers, facilitators, and strategies
2024 · Lingzi Zhong, Yanete Rodriguez, et al. · Journal of Genetic Counseling · 2
PDF
Abstract PR002: Surveillance-detected pancreatic cancers: Updated report from the PRECEDE Consortium
2026 · Raymond Wadlow, Samuel Newton, et al. · Cancer Research · 1
BRCA1/2Variants Identified Through Tumor Genomic Profiling: Assessing Genetic Counseling Outcomes
2022 · Jamie W. Harriman, Whitney F. Espinel, et al. · JCO Precision Oncology · 1
The Impact of Chatbot Type and Normative Messaging on Chatbot Usage Intention Based on the Health Technology Acceptance Model: Randomized Controlled Trial
2026 · Yi Liao, Anne Madeo, et al. · Journal of Medical Internet Research
Understanding usage intention and behavior for a health chatbot: An integrated model applied to non-Latino, English-preferring Latino, and Spanish-preferring Latino populations
2026 · Yi Liao, Anne Madeo, et al. · Computers in Human Behavior Reports
PDF
Supplemental Figure S1 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026 · Leigha Senter, Shelly Hovick, et al.
Supplemental Materials S2 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026 · Leigha Senter, Shelly Hovick, et al.
Supplemental Table S5 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026 · Leigha Senter, Shelly Hovick, et al.
Supplemental Table S2 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026 · Leigha Senter, Shelly Hovick, et al.
Works count: 39
Citation count: 278
H-index: 9
I10-index: 9
Year
Topic
Type